Introduction {#sec1_1}
============

Gestational trophoblastic neoplasia (GTN) denotes a rare group of pregnancy-related malignancies that are caused by abnormal proliferation of placental trophoblasts. GTN is an uncommon cancer, but it responds to chemotherapy very well, resulting in a high survival rate.

Similar to all cancers, early diagnosis followed by immediate and appropriate treatment yields the best outcomes; however, histopathological confirmation of GTN is not essential. A clinical diagnosis is typically made based on an abnormal pattern of serum β-human chorionic gonadotropin (β-hCG) during molar surveillance. Difficulties arise when patients present with symptoms of metastasis after a nonmolar antecedent pregnancy. In that case, GTN was diagnosed due to a rise in serum β-hCG without any evidence of pregnancy. It is even harder to diagnose GTN if the site of metastasis is uncommon.

Here, we report on a rare case of ultra-high-risk GTN with atypical gingival metastasis in which the gum lesions demonstrated a rapid response to multiagent chemotherapy. A literature review of studies on GTN with gum metastasis is also presented.

Case Report {#sec1_2}
===========

A 27-year-old G~2~P~1~A~1~ woman had developed transient alteration of consciousness and generalized tonic-clonic seizure 1 h prior to her emergency arrival at our center. Two weeks earlier, she had had hemoptysis with low-grade fever. Chest radiography (chest X-ray) at her primary care hospital had revealed a 3.1 × 4.6 × 5.0 cm mass at the lower lobe of her left lung. Pneumonia had been diagnosed and treated with intravenous antibiotics. She had then been lost to follow-up due to improvement in her symptoms. One week later, the patient had noticed multiple gum lesions and vaginal spotting.

The patient had one child by normal delivery 5 years ago, and a molar pregnancy 1 year ago. The last serum β-hCG surveillance had been performed 3 months after suction curettage with the level of approximately 400 IU/L. She had then been lost to follow-up. She had experienced amenorrhea until the last week that vaginal spotting had occurred. She had previously been healthy and sexually active with no contraception use.

Upon arrival at our center, the patient appeared slightly drowsy. Her Glasgow Coma Scale was E~3~V~4~M~5~, and no sign of neurological deficit was detected. Her vital signs were normal. She had mildly pale conjunctivae and no jaundice. She had two 7-mm purplish nodules at the outer and inner aspects of her gingiva between the upper incisors, and three 4-mm erythematous lesions around her left upper molar teeth (Fig. [1](#F1){ref-type="fig"}). Her chest, cardiac, and abdominal examination results were normal. Pelvic examination was unremarkable, except for a small amount of blood in the vagina.

A urine pregnancy test was positive. Transvaginal ultrasonography revealed a normal-sized uterus. The endometrial thickess was 3 mm. Neither an intrauterine gestational sac nor content was observed. Both ovaries were unremarkable. Her serum β-hCG level was 77,474 IU/L; thus, postmolar GTN was suspected. A metastatic survey consisting of chest X-ray and brain and abdominal computed tomography was performed. Abnormal findings included a 5-cm mass at the left lung, a 3-cm well-defined nonenhancing lesion at the right occipital lobe, and another 0.8-cm well-defined nonenhancing lesion in the right parietal region. Acute subdural hemorrhage and a 0.8-cm midline shift were also noted. As a result, the patient was staged as IV with a World Health Organization prognostic score of 14 (4 for an interval \>12 months from index pregnancy, 2 for the level of serum β-hCG, 2 for the largest tumor size at the left lung, 4 for brain metastasis, and 2 for eight metastatic lesions).

Intravenous mannitol, dexamethasone, and Dilantin were initially given to treat the cerebral edema and to prevent subsequent seizure. Etoposide, methotrexate, actinomycin D alternating with cyclophosphamide, and vincristine weekly (EMACO) were given. The patient had a dramatic response to the treatment, evidenced by resolution of the gum and lung lesions after 2 and 4 cycles of chemotherapy, respectively. She achieved normalization of her serum β-hCG level following 5 cycles of chemotherapy and 3 consolidation cycles. Currently, the patient is being surveilled, and has been remaining in complete remission after 11 months of follow-up.

Discussion {#sec1_3}
==========

GTN is a curable cancer. Complete remission can be achieved in almost all low-risk GTN patients receiving single-agent chemotherapy, while combined chemotherapy can yield a complete remission rate of up to 90% among high-risk patients \[[@B1], [@B2], [@B3]\]. Prognostic factors related to treatment failure include a histological diagnosis of choriocarcinoma, liver or brain metastasis, delayed diagnosis, and inappropriate treatment \[[@B1], [@B4]\]. Importantly, some of these risk factors are modifiable, such as delayed diagnosis. A diagnosis of GTN should be considered for patients with a past history of pregnancy, especially molar pregnancy, who present with a missed menstrual period or abnormal uterine bleeding and metastatic symptoms such as dyspnea, tachypnea, and/or seizure.

The most common metastatic sites of GTN are the lung (80%), vagina (30%), pelvis (20%), liver (10%), and brain (10%) \[[@B5]\]. The common presentations should be taken into account, and uncommon symptoms should be reported. New finding updates will improve diagnostic timeliness and accuracy and also improve the outcomes. The recognition of unusual metastatic lesions as being associated with GTN will help avoid harmful biopsy of this hypervascularized tumor, which may cause profuse and potentially lethal bleeding. Fortunately, a histopathological diagnosis is not essential for the diagnosis and treatment of GTN. However, and of concern, an inaccurate evaluation of metastatic lesions can lead to inappropriate chemotherapeutic regimens. For example, single-agent chemotherapy, which should be given in cases of low-risk GTN, may be incorrectly prescribed in cases of high-risk GTN instead of a multiagent regimen.

Very few studies have reported metastatic gum lesions from GTN. These lesions are painful and purplish in color, and they bleed easily upon contact. However, these features are nonspecific and sometimes are difficult to distinguish from common benign gingival diseases such as benign pyogenic granuloma, peripheral giant cell granuloma, or peripheral ossifying granuloma \[[@B6], [@B7], [@B8]\].

Gum metastasis in patients with GTN is extremely rare, accounting for less than 1% of all oral malignancies. In female patients, the most common primary malignancies are of the breast, genital organs, bone, and kidney \[[@B9]\]. If GTN with gum metastasis is highly suspected, such as in our case, we do not recommend performing any biopsies due to the risk of massive hemorrhage. Instead, chemotherapy is prescribed with subsequent reevaluation of the gum lesions. The response to chemotherapy supports the diagnosis of GTN.

The primary standard treatment for high-risk GTN is multiagent chemotherapy. EMACO is the most commonly used regimen, with a complete response rate of 80--90% \[[@B1], [@B2], [@B3], [@B10], [@B11]\]. However, in ultra-high-risk GTN, defined as a prognostic score of ≥12, alternative treatment can be etoposide and cisplatin alternating weekly with etoposide, methotrexate, and actinomycin D (EP/EMA), or induction with weekly cisplatin/etoposide for a few weeks prior to conventional multiagent chemotherapy, which was shown to effectuate a significant decline in early death rates due to severe side effects of full-dose chemotherapy \[[@B12]\].

Similar to our patient, previously reported cases were classified as high-risk GTN with multiple organ metastases such as to the lung or brain (Table [1](#T1){ref-type="table"}). In 2 of these 3 cases, the patients received combined chemotherapy and achieved complete remission \[[@B6], [@B8]\]. One patient had very advanced disease involving the lung, brain, liver, spleen, kidneys, peritoneum, and gingiva. That patient expired before initiation of chemotherapy due to severe coagulopathy and multiple organ failure \[[@B7]\].

Organ-specific treatment is usually not required. Local excision, radiation, or embolization is sometimes employed to relieve localized symptoms or to treat resistant lesions. Our patient presented with brain metastasis and increased intracranial pressure. We initially treated the cerebral edema with mannitol and dexamethasone, followed by EMACO administration. Dramatic improvement in symptoms was demonstrated, as well as in serum β-hCG levels and follow-up imaging results. Whole brain irradiation was not required, due to our patient\'s rapid and dramatic response to treatment. To overcome the blood-brain barrier, different strategies have been adopted to determine the adequate therapy for brain tissue, which has resulted in higher remission rates. Examples of these strategies are: increasing the dose of methotrexate to 1 g/m^2^ in EMACO, intrathecal methotrexate, combination chemotherapy and whole brain irradiation, or craniotomy with or without tumor resection \[[@B1], [@B13]\]. Based on metastatic gum cancer data, good oral hygiene should be promoted, since chronic inflammation from poor oral hygiene may contribute to various processes in tumorigenesis \[[@B9]\].
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Literature review of studies on GTN patients with gum metastasis

  Study \[Ref.\], year                Age, years   Chief complaint               Gum lesions                                                                  Metastatic sites                                     Gum biopsy             Chemotherapy                                     Outcome
  ----------------------------------- ------------ ----------------------------- ---------------------------------------------------------------------------- ---------------------------------------------------- ---------------------- ------------------------------------------------ -----------------------
  Altintas et al. \[[@B6]\], 1995     26           Painful gingival mass         Painful mass in maxillary gingiva                                            Lung                                                 Yes, choriocarcinoma   MAC, 6 cycles                                    Remission
                                                                                                                                                                                                                                                                                           
  Shafiee et al. \[[@B7]\], 2011      23           Alteration of consciousness   Ulcerative and bleeding mass in left upper gum                               Lung, brain, liver, spleen, kidney, and peritoneum   Yes, choriocarcinoma   No chemotherapy                                  Disease-related death
                                                                                                                                                                                                                                                                                           
  Alifrangis et al. \[[@B8]\], 2011   46           Toothache                     Painful and bleeding vascular lesion in left upper gum                       Lung, brain, liver, and kidney                       No                     EMACO, then TPTE with intrathecal methotrexate   Remission
                                                                                                                                                                                                                                                                                           
  Present case                        27           Alteration of consciousness   Asymptomatic purplish gingival nodules in the upper incisor and molar area   Lung and brain                                       No                     EMACO, 8 cycles                                  Remission

GTN, gestational trophoblastic neoplasia; MAC, methotrexate, actinomycin D, and cyclophosphamide; EMACO, etoposide, methotrexate, actinomycin D, cyclophosphamide, and vincristine.
